SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

4th Quarter Trading Statement

30 Mar 2010 07:00

RNS Number : 3691J
Cranswick PLC
30 March 2010
 



 

 

Cranswick plc ("Cranswick" or "the Company") - fourth quarter trading update

 

Cranswick anticipates that the Company's trading performance for the year to 31 March 2010 will be towards the upper end of market forecasts, reflecting the positive trading performance seen throughout the year.

Total sales for the year were 22 per cent higher than the previous year, excluding sales from the pet business which was sold in April 2009. The increase reflects organic growth of 11 per cent and a further contribution of 11 per cent from CCF Norfolk which was acquired in June 2009.

In the fourth quarter, excluding sales from the pet business, revenues increased by 18 per cent compared to the same period last year, of which 14 per cent was attributable to CCF Norfolk. During the period a higher proportion of fresh pork sales were made internally and there was a small reduction in sales of continental products. All other categories again delivered the strong growth seen in the first nine months of the year, with bacon sales increasing by 70 per cent and sales of fresh pork, reflecting the contribution from CCF Norfolk, 45 per cent higher. Sandwich sales were ahead by 18 per cent and sales of cooked meat and sausages were ahead by 8 per cent and 6 per cent respectively.

Operating margin in the underlying business is expected to be similar to that achieved in the first 9 months of the year, whilst progress continues to be made in driving through operational efficiencies at the CCF Norfolk site.

Cash generation from operating activities has remained strong through the final quarter resulting in year-end net debt being lower than that of a year ago.

With strong market positions, a broadening customer base and well invested plants, the Company is well placed to continue its successful development.

It is intended that the preliminary results for the year ended 31 March 2010 will be announced on 24 May 2010.

 

Enquiries:

Paul Quade 07947 186694

CityRoad Communications 020 7248 8010

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKCDQPBKDQNB
Date   Source Headline
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.